Hydralazine Hydrochloride NDC 50090-6608

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-6608Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-6608Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-6608-0	50090660800	90 TABLET in 1 BOTTLE (50090-6608-0)Marketed from Aug 22, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydralazine Hydrochloride
Generic name (nonproprietary): hydralazine hydrochloride
Active ingredients: Hydralazine hydrochloride — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088468
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Arteriolar Vasodilation (Physiologic effect)
Identifiers: Product ID 50090-6608_29ea9739-73f0-4dc5-9392-8088957cb30cSPL ID 29ea9739-73f0-4dc5-9392-8088957cb30cSPL set ID e617023e-b060-4db9-a97e-e2b11a37901eRxCUI 905395UNII FD171B778Y
Pharmacologic class: Arteriolar Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090660800 followed by a unit qualifier and the quantity

Package 50090-6608-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 28, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Essential hypertension, alone or as an adjunct.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 088468

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 088468
Product	Strength	Form · route	Labeler	Product NDC
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Cardinal Health 107, LLC	55154-0287
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Cardinal Health 107, LLC	55154-5085
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Mylan Institutional Inc.	51079-076
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Safecor Health, LLC	48433-048
Hydralazine Hydrochloride	Hydralazine hydrochloride 50 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	50111-328